Investors - Corporate Governance

Board of Directors Management Board committees Articles of Incorporation By-Laws Code of Conduct

Board of Directors
	Fabio Cavalli Executive Chairman & Chief Business Architect Fabio Cavalli serves as Mondobiotech’s Executive Chairman and Chief Business Architect and is one of the founders of Mondobiotech. He has founded several successful start-ups in IT, consumer services and sports goods fields, gaining thereby considerable marketing and sales experience. Fabio Cavalli is a Swiss citizen. He was born in 1955.
	Prinz Michael von und zu Liechtenstein Vice - Chairman Vice-Chairman and one of the founders of Mondobiotech. Prinz Michael von und zu Liechtenstein holds a degree in social sciences and business economics from the University of Vienna. He studied further in Canada and Europe and worked with Nestlé in the fields of controlling, general management and marketing, both in Europe and Africa. Since 1987, he has been the chairman of INDUSTRIE- UND FINANZKONTOR ETABLISSEMENT, a leading financial services and trust company in Liechtenstein. Prinz Michael von und zu Liechtenstein is also chairman of BIOPHARMAinvest AKTIENGESELLSCHAFT which is one of the three majority shareholders of the Company. See “12  Major Shareholders”. Prinz Michael von und zu Liechtenstein is a citizen of Liechtenstein. He was born in 1951.
	Prof. Dr. Robert Huber Nobel Prize Laureate Biochemist with a doctorate from the Technical University of Munich, and is Nobel Laureate in 1988 in chemistry along with Dr. Johann Deisenhofer and Dr. Hartmut Michael for the determination of the three-dimensional structure of a photosynthetic reaction centre. In 1972, he joined the Max-Planck-Institut für Biochemie in Martinsried, Germany, where he served as director until his retirement in 2005. He is a guest professor at the University Duisburg-Essen, at Cardiff University, at the Universidad Autonoma de Barcelona and the Universidad de Sevilla, and at the Korean German Institute of Technology, Seoul. He is member of the Scientific Advisory Board of Bayer CropScience Company, Monheim, and of the Hochschulrat der Universität Bayreuth. He co-founded two biotech companies, Proteros Biostructures GmbH and SuppreMol GmbH, both located in Martinsried. Robert Huber is a German citizen. He was born in 1937.
	Vera Cavalli Chief dasKloster Pharmacy, Mondobiotech Graduated in pharmacy at the University of Basel, serves as Mondobiotech’s Chief Pharmacy Officer and is one of the founder of Mondobiotech. She gained five years of pharmacy business experience working in various pharmacies. From 1999 to 2000, she worked in the sales department for the Swiss market of the pharmaceutical company Searle SA (Monsanto group). Vera Cavalli is a Swiss citizen. She was born in 1968. Member of the Executive Committee
	Ruggero Gramatica CEO, Mondobiotech Ruggero Gramatica has an extensive depth and breadth of experience in startups and companies’ turnaround particularly in the services industry.  Bringing strategic leadership as well as technological and operational expertise to bear.  Ruggero holds an Engineering degree from the Politecnico di Milano University, an MBA from the University of Chicago and is currently pursuing a PhD in Applied Mathematics researching the field of Econophysics at King’s College London. Ruggero has contributed to the growth and expansion of 6 successful start-up companies (including Fastweb, Covad Communications, PacificBell, Omnitel-Vodafone, Bulldog and OnTelecoms) contributing to the establishment of DSL Broadband and GSM cellular services in the United States and across Europe. Amongst these ventures Ruggero was one of the founders of FastWeb, an innovative Italian telecommunications operator that pioneered 'triple-play' on fiber-to-the-home networks and xDSL access technology. Ruggero was Founder and Chief Executive Officer of NextEdge Partners, an international consultancy firm set up providing advisory services and consultancy to Communication Providers across Europe. The company specialized in Mergers and Acquisitions and key projects included the acquisition of Bulldog Communications and Monaco Telecoms for Cable and Wireless plc and the start-up of Erenis and its sale. Consultancy clients included Swisscom, Deutsche Telecom and Cable and Wireless. Ruggero Gramatica was one of the founders and Chief Executive Officer of OnTelecoms SA and remains a Board Member of both the operating and holding companies. He was born in 1965. Member of the Executive Committee
	Prof. Michael Alan Keller Stanford University Librarian Prof. Michael Alan Keller earned a bachelor of arts in biology and music from Hamilton College and master degrees from the New York State University in musicology and library science. He is Stanford University’s librarian, director of Academic Information Resources, founder and publisher of High Wire Press, publisher of Stanford University Press and has led libraries at Cornell, Berkeley and Yale. Michael Keller was a leader in exploiting the Internet and the World Wide Web as a free communication place for exchange of information using mass digitisation, generating new services, creating innovative publishing environments, and identifying new potential for research. Michael Keller’s board service includes Research Data and Information of the National Research Council of the National Academy of Sciences USA, Hamilton College, Long Now Foundation, Bibliotheca Alexandrina and National Institute for Informatics of Japan. Michael Keller is an a.b.d. in musicology from New York State University. He was senior lecturer in musicology at Cornell and at Stanford. He is a guest professor at the Chinese Academy of Sciences, Senior Presidential Fellow of the Council on Library and Information Resources, advisor and consultant to numerous colleges, universities, foundations, scientific and scholarly societies, for the city of Ferrara, Italy, Newsweek magazine, the National Library of China, the National Library of Israel, the British Library, and the King Abdullah University of Science and Technology. He was a founder and then president of the Digital Library Federation. Michael Keller is a Siemens Stiftung 2008 Lecturer, Distinguished Senior Presidential Fellow of the Council on Library and Information Resources and fellow of the American Association for the Advancement of Science. Michael Keller is a US citizen. He was born in 1945.
	Prof. Dr. med. Thomas Cerny Head of Oncology, University of St. Gallen Graduated from the Medical School of the University in Berne, Switzerland, where he also became a professor for medical oncology. Since 1998, Thomas Cerny is Head of Medical Oncology-Hematology Department at the Kantonsspital of St. Gallen, St. Gallen, Switzerland. Currently, he is the President of the Swiss Cancer League and member of numerous international cancer associations, aiming to develop new diagnostics and medications for cancer patients. Thomas Cerny is a Swiss citizen. He was born in 1952.
	Prof. Roland M. du Bois Professor of Respiratory Medicine, National Jewish Health, Denver, Colorado and Imperial College, London Prof. Roland M. du Bois is Professor of Medicine at National Jewish Health in Denver, Colorado and at Imperial College, London. He is also a member of the American Thoracic Society, American College of Chest Physicians, European Respiratory Society and British Thoracic Society. His research areas are the genetics of chronic fibrosing lung disease, cellular and molecular biology, autoimmunity/rheumatology, environmental and occupational diseases, and interstitial lung diseases (ILD)/pulmonary fibrosis. In Denver, Prof. du Bois works on a variety of programmes including: the development of a rheumatological lung disease program to define the clinical and molecular phenotypes of lung disease that occur in rheumatological disease; a program of research into hypersensitivity pneumonitis across the divisions of Pulmonary Medicine and Occupational and Environmental Health Sciences; studies into the genetic background to fibrosing and granulomatous lung disease in the Center for Genes, Environment, and Health. In each of these endeavors, a common goal is to bridge basic and clinical science into a bonded multidisciplinary translational research program with the patient at the core. He was born in 1949.
	Robert E. Patterson Robert E. Patterson, Esq., Managing Director, Peninsula Ventures - Menlo Park, California Robert Edward Patterson is an experienced and highly regarded venture capitalist based in Silicon Valley. In addition to receiving a Bachelor of Arts degree in Physics from the University of California at Los Angeles, Mr. Patterson served as a Lieutenant Commander in the U.S. Navy, completing extensive training in nuclear physics as pertaining to pressurized water thermal neutron reactors, propulsion engineering, nuclear weapons, strategic submarine operations and military intelligence. Mr. Patterson attended the Stanford University School of Law, receiving his Juris Doctor in 1972. He was the Inaugural Fellow of the Center for Private Equity and Entrepreneurship at the Tuck School of Business at Dartmouth College. Mr. Patterson was a corporate lawyer with a 35-year tenure at Squire, Sanders & Dempsey, specialized in high technology venture investing and international business of all types. Mr. Patterson’s long and illustrious career includes serving as an initial board member of numerous biotechnology and pharmaceutical corporations, including Sequenom (NASDAQ), Synzyme Technologies LLC, Procyte Corporation (NASDAQ), Medical Research Inc., MARC Analysis Research Corporation and InPro Biotechnology Inc. Mr. Patterson was a founding partner of Peninsula Ventures, and President of its predecessor U.S. venture fund, Thompson Clive Inc., investing in biotechnology companies and other businesses. Current board directorships include, among others, Factor Technology Group, SynZyme Technogies LLC and Sumida Corporation (Tokyo Stock Exchange-Tier One). He was born in 1942.
	Graf Francis von Seilern-Aspang CEO of Industrie - und Finanzkontor Etablissement Graf Francis von Seilern-Aspang is CEO of Industrie - und Finanzkontor Etablissement, a financial services institution based in the Principality of Liechtenstein. Born in 1954, his international professional career has included senior management positions in the fields of trust administration, insurance and asset management in Spain, Austria, Italy, Switzerland, Liechtenstein and the United Kingdom. He was born in 1954.
	Prof. Geoffrey West Professor Prof. Geoffrey West is Distinguished Professor and former President of the Santa Fe Institute (SFI). He is a visiting Professor at Imperial College in London and an associate Fellow at the Said Business School, Oxford University. Prior to joining the Santa Fe Institute as a Distinguished Professor in 2003, he was the leader and founder of the high energy physics group at Los Alamos National Laboratory, where he is one of only approximately ten Senior Fellows. He received his BA from Cambridge University in 1961 and his doctorate from Stanford University in 1966, where he returned in 1970 to become a member of the faculty. He was named SFI President in July 2005. Geoffrey West is a theoretical physicist whose primary interests have been in fundamental questions in physics and biology, ranging from the elementary particles, their interactions and cosmological implications to universal scaling laws and a unifying quantitative framework of biology. His research areas include metabolic rate, growth, aging, sleep, cancer, and ecosystems. He has recently been working on extensions to an underlying theory of cities, companies and long-term sustainability; problems include rates of growth and innovation, and the accelerating pace of life. He is the author of several books and a Fellow of the American Physical Society. Among recent awards are the Mercer Prize, Ecological Society of America; the Weldon Memorial Prize for Mathematical Biology and the Glenn Award for Aging research. His work was selected as a breakthrough idea of 2007 by Harvard Business Review and he was selected for Time magazine's list of "100 Most Influential People in the World" in 2006. He was born in 1940.

Management
	Ruggero Gramatica CEO and Board Member Ruggero Gramatica has an extensive depth and breadth of experience in startups and companies’ turnaround particularly in the services industry.  Bringing strategic leadership as well as technological and operational expertise to bear. Ruggero holds an Engineering degree from the Politecnico di Milano University, an MBA from the University of Chicago and is currently pursuing a PhD in Applied Mathematics researching the field of Econophysics at King’s College London. Ruggero has contributed to the growth and expansion of 6 successful start-up companies (including Fastweb, Covad Communications, PacificBell, Omnitel-Vodafone, Bulldog and OnTelecoms) contributing to the establishment of DSL Broadband and GSM cellular services in the United States and across Europe. Amongst these ventures Ruggero was one of the founders of FastWeb, an innovative Italian telecommunications operator that pioneered 'triple-play' on fiber-to-the-home networks and xDSL access technology. Ruggero was Founder and Chief Executive Officer of NextEdge Partners, an international consultancy firm set up providing advisory services and consultancy to Communication Providers across Europe. The company specialized in Mergers and Acquisitions and key projects included the acquisition of Bulldog Communications and Monaco Telecoms for Cable and Wireless plc and the start-up of Erenis and its sale. Consultancy clients included Swisscom, Deutsche Telecom and Cable and Wireless. Ruggero Gramatica was one of the founders and Chief Executive Officer of OnTelecoms SA and remains a Board Member of both the operating and holding companies. He was born in 1965. Member of the Executive Committee
	Fabio Cavalli Executive Chairman, Chief Business Architect and Founder Fabio Cavalli is Mondobiotech’s Executive Chairman, Chief Business Architect and one of the founders of Mondobiotech. Fabio Cavalli has founded several successful start-ups in IT, consumer services and sports goods fields, gaining thereby considerable marketing and sales experience. Fabio Cavalli was born in 1955.
	Dr. habil. Dorian Bevec Scientific Auditor-in-Chief and Founder Dr. habil. Dorian Bevec is Mondobiotech’s Chief Science Officer and Scientific Auditor-in-Chief and a co-founder of Mondobiotech. Dorian Bevec holds a Ph.D. (Dr. rer. nat.) from the Ludwig-Maximilians-University of Munich and a habilitation (Venia Docendi) from the University of Vienna. Prior to that, Dorian Bevec had been working as Head of Molecular Biology and project team leader at the Sandoz Research Institute in Vienna for ten years and at Axxima AG in Martinsried for two years. Dorian Bevec was born in 1957. Member of the Executive Committee
	Vera Cavalli Chief KlosterPHARMACY, Founder and Board Member Vera Cavalli is Mondobiotech’s Chief Pharmacy Officer and one of the founders of Mondobiotech. Vera Cavalli graduated in pharmacy at the University of Basel. Prior to that, she gained five years of pharmacy business experience working in various pharmacies. From 1999 to 2000 she worked in the sales department for the Swiss market of the pharmaceutical company Searle SA (Monsanto group). Vera Cavalli was born in 1968. Member of the Executive Committee
	Patrick Pozzorini CFO and Founder Patrick Pozzorini is Mondobiotech’s Chief Financial Officer and one of the founders of Mondobiotech. Patrick Pozzorini holds a degree in business economics from the University of Zurich. Prior to that, Patrick Pozzorini was Chief Financial Officer for a start-up company active in the field of the web based enterprise management. From 1995 to 2000, he worked for PricewaterhouseCoopers AG and from 1992 to 1995 for Fidinam Group. Patrick Pozzorini was born in 1967. Member of the Executive Committee
	Maria Teresa D'Antonangelo Bühlmann COO Maria Teresa has obtained a degree in law at the University of Parma in 2000 and is admitted to bar since 2003. She gained an in-depth knowledge and experience in international commercial law and intellectual property law, with a specialization in patents and copyright. Her professional experience started with the a post degree work at the University of Parma, where she was then admitted to the Doctorate in Commercial Law and Intellectual Property. Then, she worked in the international law firm Freshfield Bruckhaus Deringer in Milan, where she was assisting international leading software companies and worldwide leading magazines for copyright infringement. Maria Teresa joined then the Intellectual Property Law Office of Avvocati Associati in Milan, working for many years together with Prof. Mario Franzosi in international patent litigations, assisting biotech, pharmaceutical and international fashion industry in licensing and patent infringement litigations worlwide.  Maria Teresa is author of many publications in the field of Copyright and Patent Law and was participating as author to the Commentary of the new Italian Intellectual Property Code. She joined mondoBIOTECH in 2005 as Legal Counsel and moved then in 2006 to the role of Chief Operating Officer. Maria Teresa is born in 1973.